En español

AIDS Research Program (ARP)

What We Do:

NIDA AIDS research program logo

Established in February 2005, NIDA's AIDS Research Program (ARP) utilizes a multifaceted approach to support HIV/AIDS research within NIDA as well as across NIH Institutes and other DHHS agencies. The primary goal of ARP is to support the development, planning, and coordination of HIV/AIDS priority research within NIDA's intramural and extramural programs, in order to ensure an integrated vision and strategy to guide HIV/AIDS research throughout NIDA.

ARP provides direction and leadership for the ongoing development of an innovative and multidisciplinary HIV/AIDS research portfolio that addresses the current and unique dimensions of drug use and abuse as they relate to HIV/AIDS. The development and implementation of NIDA's HIV/AIDS Research Program is guided by the role of drug use and its related behaviors in the evolving dynamics of HIV/AIDS epidemiology, natural history/pathogenesis, treatment, and prevention, in coordination with the current priorities and objectives of the FY 2015 Trans-NIH Plan for HIV-Related Research and FY 2016 congressional Budget Justification (PDF, 740KB)

See also – Message from the ARP Director.

NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

An important new guidance setting NIH HIV/AIDS research priorities and guidelines for funding has been issued, and we wish to call this Notice to the attention of the NIDA HIV/AIDS research community http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html

NIH HIV/AIDS Research Priorities, 12-11-2015 (PDF, 751KB)

Also see NIH Director, Dr. Collins Statement on NIH Efforts to Focus Research to End the AIDS Pandemic (August 12, 2015)

Research and Training Opportunities:

Research Priorities:


Program Staff:

Additional Links of Interest:

Mailing Address:

AIDS Research Program
National Institute on Drug Abuse
6001 Executive Blvd, MSC 9581
Bethesda, MD 20892

This page was last updated June 2015

Get this Publication

    The new Avenir awards focus on HIV/AIDS and epigenetics research


    Director Nora Volkow presenting at the AIDS 2012 conference

    New Frontiers in NIH AIDS Research at the XIX International AIDS Conference

    National HIV/AIDS Strategy